Brenntag to showcase latest pharma innovation at CPHI India 2025
A key highlight will be Brenntag’s qualified amino acids portfolio
A key highlight will be Brenntag’s qualified amino acids portfolio
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
The event will be attended by 35,000+ industry professionals
Expanding US operations to address the increased demand for API development and manufacturing
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
Subscribe To Our Newsletter & Stay Updated